teloxantrone has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BĂ©langer, K; Eisenhauer, E; Grillo-Lopez, A; Jolivet, J; Maroun, J; Stewart, D; Wainman, N; Whitfield, L | 1 |
Eisenhauer, E; Erlichman, C; Kerr, IG; Moore, M; Whitfield, LR; Wong, B; Zee, B | 1 |
2 trial(s) available for teloxantrone and Neoplasms
Article | Year |
---|---|
Phase I pharmacokinetic study of DUP-937, a new anthrapyrazole.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Drug Administration Schedule; Female; Hematologic Tests; Humans; Injections, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Pyrazoles | 1993 |
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937).
Topics: Adult; Aged; Agranulocytosis; Anthraquinones; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutropenia; Pyrazoles | 1991 |